-
Surgery could cure testicular cancer for some, study finds
A recent study found surgery may be an effective alternative to radiation and chemotherapy for patients with early metastatic testicular cancer. -
Mount Sinai's esophagectomy program earns 3-star rating from Society of Thoracic Surgeons
New York City-based Mount Sinai Health System's esophagectomy program received the Society of Thoracic Surgeons' highest rating, according to an April 4 hospital release. -
FDA stops cancer drug trial after 2 patient deaths
The FDA handed Gossamer Bio, a biotech company, a partial clinical hold after two patients died in its BTK inhibitor trial, EndPoints News reported April 3. -
HHS debuts plan to achieve Cancer Moonshot goals
HHS has released a national cancer plan, developed by the National Institutes of Health's National Cancer Institute, that aims to "reduce the cancer death rate by at least half within 25 years," which is the goal of President Joe Biden's Cancer Moonshot initiative. -
'How do I maintain my lifestyle?': Cancer patients choosing less treatment despite higher risks
More cancer patients are choosing less treatment in order to maintain their lifestyle, The Wall Street Journal reported April 2. -
Wellstar opens $12M cancer center
Roswell, Ga.-based Wellstar North Fulton Hospital opened its $12 million comprehensive cancer center March 23, Appen Media reported. -
Johns Hopkins study may upend theory of chromosome instability's link to cancer
According to Johns Hopkins Medicine researchers, their recent study may upend a long-held theory of chromosome instability contributing to cancer risk for people with short telomeres. -
Georgia system among 1st to offer Y90 liver cancer treatment to pediatric patients
Children's Healthcare of Atlanta is one of the first pediatric centers to offer Y90 Radioembolization treatment to pediatric patients with liver cancer. -
New endometrial cancer treatment can reduce recurring tumors by 70%
A combination of immunotherapy and chemotherapy could help women with advanced endometrial cancer live longer, NBC News reported March 27. -
Why Mount Sinai isn't waiting 4 years to launch its new cancer center's initiatives
While the new Tisch Cancer Hospital at New York City-based Mount Sinai Hospital will not officially open completely until 2027, new "patient-centric" treatment initiatives, inspired by the promise of the state-of-the-art facility, are already being added to protocols at the Tisch Cancer Center. -
A future with personalized breast cancer care? Yes, says Johns Hopkins report
New breast cancer research out of Johns Hopkins' Sidney Kimmel Comprehensive Cancer Center reveals the cellular, microbial and genomic makeup of cancerous breast tumors differ greatly between white, Black and Asian women. This information "could potentially be used to personalize care or predict disease progression," according to a Johns Hopkins March 27 release. -
FDA dense breast guideline shouldn't trigger 'knee-jerk' reactions, Mount Sinai surgeon says
When the FDA updated the 1992 Mammography Quality Standards Act to require patients be informed directly if they have dense breasts, the move may have opened a "Pandora's box," Elisa Port, MD, chief of breast surgery at New York City-based Mount Sinai Health System and director of the Dubin Breast Center at Mount Sinai, told Becker's. -
Penn Medicine Princeton receives $2.5M for geriatric oncology program
Plainsboro, N.J.-based Penn Medicine Princeton Cancer Center received $2.5 million to fund its geriatric oncology program. -
New FDA guidance updates clinical trials for accelerated oncology drug approval
The FDA issued draft guidance for clinical trials of oncology drugs in the accelerated approval application. -
Some antibiotics improve pancreatic cancer survival by 11%: Study
A recent study found that adding gemcitabine antibiotics with chemotherapy can improve survival rates by 11 percent for patients with a subset of pancreatic cancer. -
Fred Hutch set to open $320M cancer clinic
Seattle-based Fred Hutchinson Cancer Center is set to open its $320 million, 150,000-square foot clinic building. -
This program cut cancer diagnosis time from 32 days to 12 for underserved populations
Boston-based Dana-Farber Cancer Institute researchers found a way to reduce cancer diagnosis time from 32 days to 12 for underserved populations, The ASCO Post reported March 22. -
All hormonal contraceptives have increased risk of breast cancer, study says
A recent study found progestogen-only contraceptives have a similar risk of breast cancer as combined hormone options, NBC News reported March 21. -
Fox Chase Cancer Center tests less invasive treatment for prostate cancer
Philadelphia-based Fox Chase Cancer Center is trying a less invasive treatment for prostate cancer that does not necessitate removal of the organ, CBS Philadelphia reported March 21. -
Some 'reinvention' opportunities from pandemic are here to stay, COO says
The COVID-19 pandemic brought on a tidal wave of challenges across all healthcare systems. And cancer hospitals and oncology departments had to manage not only those rapidly increasing concerns but also the critical timeliness associated with managing cancer patients.
Page 11 of 50